ERBB2 and esophageal cancer: The amplification or overexpression of the Human Epidermal Growth Factor Receptor 2 (HER2) has been implicated in the pathogenesis of a diverse array of malignancies, encompassing breast, bladder, pancreatic, gallbladder, and esophageal cancers [32].